A5041009885- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- Intensive Care Unit Cognitive Disorders
- Autism Spectrum Disorder Research
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- COVID-19 Digital Contact Tracing
- Folate and B Vitamins Research
- Nerve injury and regeneration
- Infectious Encephalopathies and Encephalitis
- Psychosomatic Disorders and Their Treatments
- Myasthenia Gravis and Thymoma
- Vaccine Coverage and Hesitancy
- Immune responses and vaccinations
- Nuclear Receptors and Signaling
- Healthcare during COVID-19 Pandemic
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2020-2021
Universidade de São Paulo
2020
University of Brescia
2008
ABSTRACT Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing conditions may require special treatment be associated with worse outcomes. Notwithstanding, the role neurologists in is probably underrecognized. Objective: The aim this study was report reasons for requesting consultations by internists intensivists a COVID-19-dedicated hospital. Methods: This retrospective carried out at...
To describe the clinical, neurological, neuroimaging, and cerebrospinal fluid (CSF) findings associated with encephalopathy in patients admitted to a COVID-19 tertiary reference center. We retrospectively reviewed records of consecutive evaluated by consulting neurology team from March 30, 2020 through May 15, 2020. Fifty-five confirmed SARS-CoV-2 were included, 43 whom showed encephalopathy, further divided into mild, moderate, severe groups. Nineteen (44%) had undergone mechanical...
Abstract Objective To describe the clinical, neurological, neuroimaging and cerebrospinal fluid (CSF) findings associated with encephalopathy in patients admitted to a COVID-19 tertiary reference center. Methods We retrospectively reviewed records of consecutive evaluated by consulting neurology team from March 30, 2020 through May 15, 2020. Results Fifty-five confirmed SARS-CoV-2 were included, 43 whom showed encephalopathy, further divided into mild, moderate severe groups. Nineteen (44%)...